During the past decade, Mount Sinai Rehabilitation Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Rehabilitation Hospital" are "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Mount Sinai Rehabilitation Hospital" in a lesser frequency.

Most popular intervention types in "Mount Sinai Rehabilitation Hospital" are "Behavioral" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dalfampridine-ER 10mg" (1 trials), "Dalfampridine-ER 5mg" (1 trials), "Educational" (1 trials), "Placebo" (1 trials) and "Prospective Memory Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Rehabilitation Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mount Sinai Rehabilitation Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mount Sinai Rehabilitation Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Rehabilitation Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".